Table 3.
Effect of clinical factors on PMA in weeks at successful NCPAP weaning.
| Present* | Absent* | P-value | |
|---|---|---|---|
| Antenatal steroids | 32.9±2.5 | 32.7±2.2 | P = 0.38 |
| Chorioamnionitis | 34.1±2.8 | 32.9±2.4 | P < 0.02 |
| Preeclampsia | 32.5±2.2 | 33±2.5 | P = 0.14 |
| Magnesium sulphate use | 33.1±2.7 | 32.8±2.2 | P = 0.26 |
| IUGR | 33.1±2.2 | 32.9± 2.5 | P = 0.72 |
| Intubation | 35.0±2.9 | 32.1±1.7 | P < 0.00001 |
| PDA | 34.2±2.9 | 32.2±1.7 | P < 0.0001 |
| Sepsis/NEC | 34.2± 2.5 | 32.8±2.4 | P < 0.0001 |
| Anemia | 33.7±2.8 | 31.8±1.2 | P < 0.0001 |
| Apnea | 33.9±2.6 | 32.7±2.3 | P < 0.0001 |
| GE reflux | 35.6± 3.5 | 32.8±2.3 | P < 0.00001 |
| IVH (grades3/4) | 34.5±3.4 | 32.6±2.1 | P < 0.0001 |
* PMA is reported as mean ±SD.
Abbreviations: IUGR: intrauterine growth retardation, PDA: patent ductus arteriosus, NEC: necrotizing enterocolitis, GE Reflux: gastroesophageal reflux, IVH: intraventricular hemorhage.